Company Filing History:
3 out of 60 
1 out of 410 
Years Active: 2019-2025
Title: **Serena Nelson: Innovating in Metabolic Disease Treatment**
Introduction
Serena Nelson is a distinguished inventor based in San Diego, California, recognized for her contributions to the field of biomedicine. With a portfolio of three patents, her work focuses on innovative solutions for treating metabolic diseases. Her cutting-edge research combines molecular biology and protein engineering to develop promising therapeutic strategies.
Latest Patents
Among her notable innovations, Nelson's latest patents include groundbreaking fusion proteins aimed at addressing metabolic disorders. The first patent, titled "Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereof," introduces GLP1-GDF15 fusion proteins designed to enhance treatment efficacy. These proteins comprise a GLP1 or GLP1 variant peptide, along with a series of linker peptides and serum albumin proteins.
Her second patent, "GDF15 fusion proteins and uses thereof," describes innovative fusion proteins containing a half-life extension protein, a linker, and a GDF15 protein. This patent also includes invaluable descriptions of nucleic acids encoding the fusion proteins and compositions for therapeutic use, highlighting methods for treating or preventing various metabolic diseases.
Career Highlights
Throughout her career, Serena Nelson has collaborated with prominent organizations in the biotechnology sector. She has worked with Janssen Sciences Ireland Unlimited Company and Janssen Biotech, Inc., contributing to the advancement of drug development in metabolic health.
Collaborations
Nelson has worked closely with talented colleagues in the industry, including Jennifer Furman and Chichi Huang. Together, they have forged a collaborative environment that fosters innovation and efficiency in research and development.
Conclusion
Serena Nelson's innovative spirit and scientific expertise continue to make significant strides in healthcare. Her patents not only contribute to the understanding of metabolic disease treatment but also pave the way for new therapeutic avenues. As an influential inventor, she exemplifies the impact that professionals can have on improving patient outcomes through innovation.